Biosynthesis of doped zinc oxide enhances photocatalytic efficiency in environmental applications.
Biosynthesis of undoped ZnO, Ni (2 wt. %)-doped, Ni (2 wt.%) and Fe (2 wt. %) co-doped ZnO via andrographis paniculata leaf extract was demonstrated. Phase singularity as well as hexagonal phase was confirmed through XRD characterization, which was not disturbed by Ni-single and Ni-Fe-double doping. The reduction in crystallite size and lattice cell parameters, the change of peaks along the higher 2θ side, and the stable c/a ratio confirmed that Ni 2+ and Fe 2+ are correctly added in Zn-O sites, with no change in their crystal structure. The morphology of the particles and the presence of the elements were confirmed through SEM-EDS analysis. The enhanced light absorption and the tuning of the band gap (3.89 – 3.94 eV) by the inclusion of Ni/Fe showed a blueshift due to doping. The occurrence of Ni and Fe in the Zn-O lattice was recognized by FTIR examination, together with other functional groups. The origin of UV, violet, and blue emissions is ascertained to NBE, and a defect-related transition due to dopants is explored using an energy level diagram. The increased separation of charges; higher visible-range optical absorbance; enhanced surface area; as well as the existence of defect-based states lead to the better photocatalytic degradation efficiency that has been observed in Ni/Fe-doped ZnO. This improved photocatalytic behavior was tested with methylene blue and tetracycline. The Ni, Fe-doped ZnO exhibited a better degradation efficiency, and these materials will be useful for environmental remediation.
No takes yet. Share an insight, caveat, or question.
Rakchana et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: